Teva Pharmaceutical Industries Ltd 10-K for FY2025
Teva Pharmaceutical Industries Ltd (TEVA)
10-K
2026-02-03
For: 2025-12-31
View Original
Added on
April 03, 2026
About this 10-K
Teva Pharmaceutical Industries Ltd filed this 10-K on February 3, 2026, covering the fiscal year ended December 31, 2025 (FY2025).
Headline figures
Fiscal year ended December 31, 2025, as reported in this filing, compared with the same period a year earlier where the filing states it.
- Revenue
- $17.26B
- up 4.3% from $16.54B a year earlier
- Net income
- $1.41B
- compared with a net loss of $1.64B a year earlier
- Diluted EPS
- $1.21
- compared with -$1.45 a year earlier